Ares Capital Corporation Profile Avatar - Palmy Investing

Ares Capital Corporation

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and gen…
Asset Management
US, Los Angeles [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 50% Balanced
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 1128.31 -665.30 54.16
Graham Fair Price 3.89 18.53 17.84
PEG 232.63 1.21 -0.36
Price/Book -0.77 1.02 1.02
Price/Cash Flow -1698.05 -573.83 -31.91
Prices/Earnings -3.25 6.71 6.94
Price/Sales -5.66 24.34 25.80
Price/FCF -1698.05 -573.83 -31.91
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 147.55 1.42 0.57
Operating Margin 4.36 0.99 0.95
ROA 6.67 0.02 0.02
ROE 0.04 0.04 2.57
ROIC 0.02 0.02 14.64
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.02 0.03 -49.13
Dividends QOQ 0.02 < 0.005 -63.14
EBIT QOQ 0.45 0.16 -63.27
EPS QOQ -0.19 0.06 -70.92
FCF QOQ -8.80 0.94 -89.31
Revenue QOQ -0.16 0.11 -27.80
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 390.79 0.44 -99.89
Days Sales Outstanding (DSO) 52.91 84.36 59.46
Inventory Turnover 0.23 206.00 89347.37
Debt/Capitalization 0.52 0.50 -3.56
Quick Ratio 2.13 1.70 -20.21
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 19.58 20.09 2.58
Cash 0.94 0.86 -7.74
Capex 0.00 0.00 0.00
Free Cash Flow -0.63 -0.04 94.34
Revenue 0.78 0.84 7.90
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.13 1.82 -14.72
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 27.01 -321.00 1088.26
Naive Interpretation Member
06 - Financial Health · Weak
End of ARCC's Analysis
CIK: 1287750 CUSIP: 04010L103 ISIN: US04010L1035 LEI: - UEI: -
Secondary Listings
ARCC has no secondary listings inside our databases.